MedTrace Logo

Use of Botulinum Toxin A in Direct Eyebrow Lift Scar

NCT06465056 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-06-18

No results posted yet for this study

Summary

Prospective, controlled and randomized study in which participants indicated for surgery to direct eyebrow lift will be randomized into two groups. In addition to surgery, the patients will be treated with botulinum toxin in one eyebrow and saline (placebo) in the other site. The patients participate as treatment and placebo at the same time. Assessments will be carried out through non-invasive exams.

Conditions

  • Skin Scarring
  • Eyebrow Ptosis

Interventions

DRUG

Botulinum toxin type A

Botulinum toxin application between 3-14 days after direct eyebrow lift surgery.

Sponsors & Collaborators

  • University of Campinas, Brazil

    collaborator OTHER

  • Faculdade de Medicina do ABC

    collaborator OTHER

  • University of Sao Paulo

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2025-01-01
Completion
2026-01-01

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06465056 on ClinicalTrials.gov